Nimorazole may increase the effect of phenprocoumon.
Bjarnason
Nina H
NH
Specht
Lena
L
Dalhoff
Kim
K
D000368:Aged; D000925:Anticoagulants / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D004347:Drug Interactions; D006469:Hemoptysis / Q000139:chemically induced; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy; D008297:Male; D009554:Nimorazole / Q000009:adverse effects* / Q000627:therapeutic use*; D010644:Phenprocoumon / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000925:Anticoagulants; D000994:Antitrichomonal Agents; D009554:Nimorazole; D010644:Phenprocoumon